PHILIPS NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.56 USD | -0.75% |
|
+28.19% | +13.84% |
| 02:08pm | PHILIPS NV : DZ Bank reiterates its Neutral rating | ZD |
| 01:03pm | Moody's Affirms Royal Philips' Rating, Upgrades Outlook on Enhanced Performance | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Weaknesses
- With an expected P/E ratio at 52.32 and 22.49 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +13.84% | 24.39B | - | ||
| +7.62% | 219B | B | ||
| +6.70% | 183B | B- | ||
| +11.94% | 132B | B- | ||
| +24.60% | 106B | A- | ||
| -2.66% | 62.09B | A- | ||
| +4.81% | 50.88B | B+ | ||
| +11.55% | 50.8B | B+ | ||
| -1.09% | 40.64B | A | ||
| +26.82% | 31.59B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PHIA Stock
- PHG Stock
- Ratings Philips NV
